Akademik Veri Yönetim Sistemi
Journal of Experimental and Clinical Medicine (Turkey), cilt.39, sa.4, ss.1270-1276, 2022 (Scopus)
Bone marrow transplantation is now called hematopoietic stem cell transplantation (HSCT) because, apart from bone marrow, peripheral blood and umbilical cord blood can also be used as stem cell sources. HSCT can be performed in three ways. One is autologous stem cell transplantation. The other is allogeneic stem cell transplantation. Another type of transplantation applied in recent years is haploidentic transplantation. More than 20% of all allogeneic HSCTs are performed in patients under 20 years of age. HSCT has become a well-established lifesaving treatment procedure for many patients with hematological malignancies, hemoglobinopathies, inborn errors, or bone marrow failure syndromes. HSCT is now integrated as an essential part in many treatment concepts and protocols. HSCT is a treatment that provides an increase on success compared to other treatments when it is performed in suitable patients and in accordance with the standards. Selection of the appropriate transplant type, appropriate donor, appropriate preparation regimen, and close monitoring of complications are essential.